HEALTH● LOW1h ago · Oct 13, 2026, 9:37 PM
AbbVie releases phase 3 induction therapy data on injectable Skyrizi for Crohn's
Seeking Alpha Tech · global
AbbVie has released phase 3 induction therapy data for its injectable drug Skyrizi, developed for the treatment of Crohn's disease. This provides an update on the clinical development of a potential new medical treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH36m agoUN General Assembly adopts pandemic declaration, urges stronger global cooperationPremium TimesHEALTH37m agoPennsylvania at the center of US measles outbreaksThe HillHEALTH41m agoPope Leo's brother also battling cancer, wife tells CBS NewsCBS NewsHEALTH58m agoPope Leo has lung cancer, the Vatican announces after surgeryNPR News